Zoltán Kaló is a Professor of Health Economics at the Center for Health Technology Assessment (HTA) of Semmelweis University in Budapest, where he is leading a PhD program in HTA.
Dr. Kaló is also the lead partner of Syreon Research Institute, an international corporation implementing research projects and facilitating capacity building initiatives in the fields of health technology assessment, health and food policy.
He has 25+ years of international experience in academia and industry, specializing in health systems design, HTA implementation, health economics and outcomes research, patient access and pricing policies of healthcare technologies.
Dr. Kaló serves as a policy advisor to public decision-makers, global health care corporations and scientific societies. Between 2016-2021 he was a Scientific Committee member of the Innovative Medicines Initiative (IMI), the largest public-private partnership of the European Union in the field of health care innovation. He was a Director and Board Member of ISPOR (the Professional Society for Health Economics and Outcomes Research) between 2012-2014 and received the Marilyn Dix Smith Leadership Award of ISPOR for his contribution to the society in 2021.
Selected list of publications: https://www.ncbi.nlm.nih.gov/myncbi/zoltan.kalo.1/bibliography/public/